BioWorld Asia

Nov. 20, 2002

View Archived Issues

Animal Breeders Could Benefit From Swiss Pheromone Findings

EuropaBio Calls On Europe To Support 'White Biotechnology'

GenOway, CopyRat Collaborate To Develop Rat Disease Models

CeNeS' Drug, Not Partner, Ready For Phase III Of Morphine Product

Due Diligence Skills Need To Be In Shape Before Deals Are Struck

Prokaria Fishing For Products In The Hot Springs Of Iceland

Synt:em, Probiodrug Partner To Develop Multiple Sclerosis Drug

Other News to Note

Medicon Valley Developing R&D Capabilities, Attracting Attention

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International) Read More

Antisoma Enters Broad Deal With Roche, Receives $43M Up Front

Today's news in brief

BioWorld

BioWorld briefs for Jan 21, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 21, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...